Tissue-specific and exosomal miRNAs in lung cancer radiotherapy: from regulatory mechanisms to clinical implications

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Nicholson AG, et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.000000000000063026291008
   PubMed Web of Science ®Google Scholar
• Lischalk JW, Woo SM, Kataria S, et al. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol. 2016;5(4):379–387. doi:10.1007/s13566-016-0273-428018523
   PubMedGoogle Scholar
• Willers H, Azzoli CG, Santivasi WL, Xia F. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J. 2013;19(3):200–207. doi:10.1097/PPO.0b013e318292e4e323708066
   PubMed Web of Science ®Google Scholar
• Rosenzweig KE, Gomez JE. Concurrent chemotherapy and radiation therapy for inoperable locally advanced non-small-cell lung cancer. J Clin Oncol. 2017;35(1):6–10. doi:10.1200/JCO.2016.69.967827870565
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.14744438
   PubMed Web of Science ®Google Scholar
• Czochor JR, Glazer PM. microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal. 2014;21(2):293–312. doi:10.1089/ars.2013.571824206455
   PubMed Web of Science ®Google Scholar
• Sun Y, Hawkins PG, Bi N, et al. Serum microRNA signature predicts response to high-dose radiation therapy in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2018;100(1):107–114. doi:10.1016/j.ijrobp.2017.08.03929051037
   PubMed Web of Science ®Google Scholar
• Malla B, Zaugg K, Vassella E, Aebersold DM, Dal Pra A. Exosomes and exosomal MicroRNAs in prostate cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2017;98(5):982–995. doi:10.1016/j.ijrobp.2017.03.03128721912
   PubMed Web of Science ®Google Scholar
• Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S. Exosomes: a new horizon in lung cancer. Drug Discov Today. 2017;22(6):927–936. doi:10.1016/j.drudis.2017.03.00428288782
   PubMed Web of Science ®Google Scholar
• Tang Y, Cui Y, Li Z, et al. Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. J Exp Clin Cancer Res. 2016;35:7. doi:10.1186/s13046-016-0444-626754670
   PubMed Web of Science ®Google Scholar
• Li L, Story M, Legerski RJ. Cellular responses to ionizing radiation damage. Int J Radiat Oncol Biol Phys. 2001;49(4):1157–1162.11240259
   PubMed Web of Science ®Google Scholar
• Hu H, Gatti RA. MicroRNAs: new players in the DNA damage response. J Mol Cell Biol. 2011;3(3):151–158. doi:10.1093/jmcb/mjq04221183529
   PubMed Web of Science ®Google Scholar
• Ma W, Ma CN, Zhou NN, Li XD, Zhang YJ. Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy. Sci Rep. 2016;6:31651. doi:10.1038/srep3165127530148
   PubMed Web of Science ®Google Scholar
• Guo Y, Sun W, Gong T, et al. miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol Rep. 2017;37(4):1980–1988. doi:10.3892/or.2017.544828259977
   PubMed Web of Science ®Google Scholar
• Chen S, Wang H, Ng WL, Curran WJ, Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int J Radiat Oncol Biol Phys. 2011;81(5):1524–1529. doi:10.1016/j.ijrobp.2011.05.03122014955
   PubMed Web of Science ®Google Scholar
• Li Y, Han W, Ni TT, et al. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells. Oncol Rep. 2015;33(6):2821–2828. doi:10.3892/or.2015.388425823795
   PubMed Web of Science ®Google Scholar
• Cortez MA, Valdecanas D, Niknam S, et al. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Mol Ther Nucleic Acids. 2015;4:e270. doi:10.1038/mtna.2015.4726670277
   PubMedGoogle Scholar
• Medema RH, Macurek L. Checkpoint control and cancer. Oncogene. 2012;31(21):2601–2613. doi:10.1038/onc.2011.45121963855
   PubMed Web of Science ®Google Scholar
• Liu Q, Fu H, Sun F, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008;36(16):5391–5404. doi:10.1093/nar/gkn52218701644
   PubMed Web of Science ®Google Scholar
• Rahmanian N, Hosseinimehr SJ, Khalaj A. The paradox role of caspase cascade in ionizing radiation therapy. J Biomed Sci. 2016;23(1):88. doi:10.1186/s12929-016-0306-827923354
   PubMedGoogle Scholar
• He Z, Liu Y, Xiao B, Qian X. miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression. Biochem Biophys Res Commun. 2015;457(3):235–241. doi:10.1016/j.bbrc.2014.12.09425576360
   PubMed Web of Science ®Google Scholar
• Zhao L, Bode AM, Cao Y, Dong Z. Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis. 2012;33(11):2220–2227. doi:10.1093/carcin/bgs23522798379
   PubMed Web of Science ®Google Scholar
• Arechaga-Ocampo E, Lopez-Camarillo C, Villegas-Sepulveda N, et al. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells. Tumour Biol. 2017;39(3). 1010428317695010. doi:10.1177/1010428317695010
   PubMedGoogle Scholar
• Ma D, Jia H, Qin M, et al. MiR-122 induces radiosensitization in non-small cell lung cancer cell line. Int J Mol Sci. 2015;16(9):22137–22150. doi:10.3390/ijms16092213726389880
   PubMed Web of Science ®Google Scholar
• Zhang HH, Pang M, Dong W, et al. miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX. Oncol Rep. 2014;31(3):1473–1479. doi:10.3892/or.2014.297324402374
   PubMed Web of Science ®Google Scholar
• Ma W, Ma CN, Li XD, Zhang YJ. Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer. Cancer Gene Ther. 2016;23(2–3):66–71. doi:10.1038/cgt.2016.226915403
   PubMed Web of Science ®Google Scholar
• Wang M, Meng B, Liu Y, Yu J, Chen Q, Liu Y. MiR-124 inhibits growth and enhances radiation-induced apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell Physiol Biochem. 2017;44(5):2017–2028. doi:10.1159/00048590729237164
   PubMedGoogle Scholar
• Zhu L, Xue F, Xu X, et al. MicroRNA-198 inhibition of HGF/c-MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non-small-cell lung cancer. J Cell Biochem. 2018;119(9):7873–7886.
   Web of Science ®Google Scholar
• Osinsky S, Zavelevich M, Vaupel P. Tumor hypoxia and malignant progression. Exp Oncol. 2009;31(2):80–86.19550396
   PubMedGoogle Scholar
• Marignol L, Coffey M, Lawler M, Hollywood D. Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev. 2008;34(4):313–327. doi:10.1016/j.ctrv.2008.01.00618334284
   PubMed Web of Science ®Google Scholar
• Harada H, Itasaka S, Zhu Y, et al. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br J Cancer. 2009;100(5):747–757. doi:10.1038/sj.bjc.660493919223896
   PubMed Web of Science ®Google Scholar
• Meijer TW, Kaanders JH, Span PN, Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res. 2012;18(20):5585–5594. doi:10.1158/1078-0432.CCR-12-085823071360
   PubMed Web of Science ®Google Scholar
• Jiang S, Wang R, Yan H, Jin L, Dou X, Chen D. MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1alpha-promoted glycolysis in non-small cell lung cancer cells. Mol Med Rep. 2016;13(5):4101–4107. doi:10.3892/mmr.2016.501027035555
   PubMed Web of Science ®Google Scholar
• Grosso S, Doyen J, Parks SK, et al. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis. 2013;4:e544. doi:10.1038/cddis.2013.7123492775
   PubMed Web of Science ®Google Scholar
• Marie-Egyptienne DT, Lohse I, Hill RP. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. Cancer Lett. 2013;341(1):63–72. doi:10.1016/j.canlet.2012.11.01923200673
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zheng L, Huang J, et al. MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1. PLoS One. 2014;9(4):e93917. doi:10.1371/journal.pone.009391724705396
   PubMed Web of Science ®Google Scholar
• Luo H, Liang C. MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1. Exp Ther Med. 2018;15(4):3609–3616. doi:10.3892/etm.2018.584529545890
   PubMed Web of Science ®Google Scholar
• Koo T, Cho BJ, Kim DH, et al. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Oncotarget. 2017;8(39):65457–65468. doi:10.18632/oncotarget.1892429029445
   PubMedGoogle Scholar
• Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R‘s of radiobiology revisited. Stem Cells. 2010;28(4):639–648. doi:10.1002/stem.31820135685
   PubMed Web of Science ®Google Scholar
• Chiou GY, Cherng JY, Hsu HS, et al. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J Control Release. 2012;159(2):240–250. doi:10.1016/j.jconrel.2012.01.01422285547
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang C, Hu L, et al. Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer. Cancer Invest. 2015;33(5):165–171. doi:10.3109/07357907.2015.101967625831148
   PubMed Web of Science ®Google Scholar
• Chen X, Wu L, Li D, et al. Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1alpha. Cancer Med. 2018;7(8):3834–3847. doi:10.1002/cam4.152729860718
   PubMed Web of Science ®Google Scholar
• Korpela E, Vesprini D, Liu SK. MicroRNA in radiotherapy: miRage or miRador? Br J Cancer. 2015;112(5):777–782. doi:10.1038/bjc.2015.625611301
   PubMed Web of Science ®Google Scholar
• Guo Y, Jiang Y, Sang M, Xu C. Down-regulation of miR-373 increases the radiosensitivity of lung cancer cells by targeting TIMP2. Int J Biochem Cell Biol. 2018;99:203–210. doi:10.1016/j.biocel.2018.04.01429673878
   PubMed Web of Science ®Google Scholar
• Wang XC, Du LQ, Tian LL, et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer. 2011;72(1):92–99. doi:10.1016/j.lungcan.2010.07.01420728239
   PubMed Web of Science ®Google Scholar
• Tian F, Han Y, Yan X, et al. Upregulation of microrna-451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis. Thorac Cancer. 2016;7(2):226–231. doi:10.1111/1759-7714.1231827042226
   PubMed Web of Science ®Google Scholar
• Yin H, Ma J, Chen L, et al. MiR-99a enhances the radiation sensitivity of non-small cell lung cancer by targeting mTOR. Cell Physiol Biochem. 2018;46(2):471–481. doi:10.1159/00048861529614485
   PubMedGoogle Scholar
• Jiang Y, Chen X, Tian W, Yin X, Wang J, Yang H. The role of TGF-beta1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells. Br J Cancer. 2014;111(4):772–780. doi:10.1038/bjc.2014.36824992582
   PubMed Web of Science ®Google Scholar
• Xiong K, Shao LH, Zhang HQ, et al. MicroRNA-9 functions as a tumor suppressor and enhances radio-sensitivity in radio-resistant A549 cells by targeting neuropilin 1. Oncol Lett. 2018;15(3):2863–2870. doi:10.3892/ol.2017.770529435012
   PubMed Web of Science ®Google Scholar
• Arora H, Qureshi R, Jin S, Park AK, Park WY. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp Mol Med. 2011;43(5):298–304. doi:10.3858/emm.2011.43.5.03121464588
   PubMed Web of Science ®Google Scholar
• Lan F, Yue X, Ren G, et al. miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-kappaB signaling pathway. Int J Radiat Oncol Biol Phys. 2015;91(1):73–81. doi:10.1016/j.ijrobp.2014.09.02125442346
   PubMed Web of Science ®Google Scholar
• Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys. 2010;76(1):5–8. doi:10.1016/j.ijrobp.2009.08.02820005451
   PubMed Web of Science ®Google Scholar
• Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D. MicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys. 2011;81(3):839–848. doi:10.1016/j.ijrobp.2010.09.04821093163
   PubMed Web of Science ®Google Scholar
• Salim H, Akbar NS, Zong D, et al. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer. 2012;107(8):1361–1373. doi:10.1038/bjc.2012.38222929890
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–1741. doi:10.1373/clinchem.2010.14740520847327
   PubMed Web of Science ®Google Scholar
• Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22(3):125–132. doi:10.1016/j.tcb.2011.12.00122260888
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb159617486113
   PubMed Web of Science ®Google Scholar
• Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A. 2010;107(14):6328–6333. doi:10.1073/pnas.091484310720304794
   PubMed Web of Science ®Google Scholar
• Templin T, Amundson SA, Brenner DJ, Smilenov LB. Whole mouse blood microRNA as biomarkers for exposure to gamma-rays and (56)Fe ion. Int J Radiat Biol. 2011;87(7):653–662. doi:10.3109/09553002.2010.54953721271940
   PubMed Web of Science ®Google Scholar
• Templin T, Paul S, Amundson SA, et al. Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. Int J Radiat Oncol Biol Phys. 2011;80(2):549–557. doi:10.1016/j.ijrobp.2010.12.06121420249
   PubMed Web of Science ®Google Scholar
• Prise KM, O‘Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009;9(5):351–360. doi:10.1038/nrc260319377507
   PubMed Web of Science ®Google Scholar
• Yuan D, Xu J, Wang J, et al. Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget. 2016;7(22):32707–32722. doi:10.18632/oncotarget.901727129166
   PubMedGoogle Scholar
• Dinh TK, Fendler W, Chalubinska-Fendler J, et al. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer. Radiat Oncol. 2016;11:61. doi:10.1186/s13014-016-0636-427117590
   PubMed Web of Science ®Google Scholar
• Urbanelli L, Magini A, Buratta S, et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes (Basel). 2013;4(2):152–170. doi:10.3390/genes402015224705158
   PubMed Web of Science ®Google Scholar
• Cui S, Cheng Z, Qin W, Jiang L. Exosomes as a liquid biopsy for lung cancer. Lung Cancer. 2018;116:46–54. doi:10.1016/j.lungcan.2017.12.01229413050
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo F, Wang B, et al. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett. 2016;370(1):125–135. doi:10.1016/j.canlet.2015.10.01126525579
   PubMed Web of Science ®Google Scholar
• Hsu YL, Hung JY, Chang WA, et al. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene. 2017;36(34):4929–4942. doi:10.1038/onc.2017.10528436951
   PubMed Web of Science ®Google Scholar
• Cui H, Seubert B, Stahl E, et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene. 2015;34(28):3640–3650. doi:10.1038/onc.2014.30025263437
   PubMed Web of Science ®Google Scholar
• Kim J, Kim TY, Lee MS, Mun JY, Ihm C, Kim SA. Exosome cargo reflects TGF-beta1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells. Biochem Biophys Res Commun. 2016;478(2):643–648. doi:10.1016/j.bbrc.2016.07.12427492069
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou J, Mei S, et al. Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med. 2017;21(6):1228–1236. doi:10.1111/jcmm.1305628026121
   PubMed Web of Science ®Google Scholar
• Adi Harel S, Bossel Ben-Moshe N, Aylon Y, et al. Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. Cell Death Differ. 2015;22(8):1328–1340. doi:10.1038/cdd.2014.22125591738
   PubMed Web of Science ®Google Scholar
• Yuwen DL, Sheng BB, Liu J, Wenyu W, Shu YQ. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2017;21(11):2650–2658.28678319
   PubMed Web of Science ®Google Scholar
• Yang M, Shen H, Qiu C, et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49(3):604–615. doi:10.1016/j.ejca.2012.09.03123099007
   PubMed Web of Science ®Google Scholar
• Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009;10(1):42–46. doi:10.3816/CLC.2009.n.00619289371
   PubMed Web of Science ®Google Scholar
• Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal mirna as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 2017;23(17):5311–5319. doi:10.1158/1078-0432.CCR-17-057728606918
   PubMed Web of Science ®Google Scholar
• Mutschelknaus L, Peters C, Winkler K, et al. Exosomes derived from squamous head and neck cancer promote cell survival after ionizing radiation. PLoS One. 2016;11(3):e0152213. doi:10.1371/journal.pone.015221327006994
   PubMed Web of Science ®Google Scholar
• Boelens MC, Wu TJ, Nabet BY, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014;159(3):499–513. doi:10.1016/j.cell.2014.09.05125417103
   PubMed Web of Science ®Google Scholar
• Cai S, Shi GS, Cheng HY, et al. Exosomal miR-7 mediates bystander autophagy in lung after focal brain irradiation in mice. Int J Biol Sci. 2017;13(10):1287–1296. doi:10.7150/ijbs.1889029104495
   PubMed Web of Science ®Google Scholar
• Wang R, Ye F, Zhen Q, et al. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer. J Physiol Biochem. 2016;72(2):337–343. doi:10.1007/s13105-016-0485-527083571
   PubMed Web of Science ®Google Scholar
• Xie P, Li X, Tan X, Sun X, Wang C, Yu J. Sequential serum let-7 is a novel biomarker to predict accelerated reproliferation during fractional radiotherapy in lung cancer. Clin Lung Cancer. 2016;17(5):e95–e101. doi:10.1016/j.cllc.2016.03.01027133539
   PubMed Web of Science ®Google Scholar
• Xu T, Liao Z, O‘Reilly MS, et al. Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer. Radiother Oncol. 2014;113(3):379–384. doi:10.1016/j.radonc.2014.11.00625466375
   PubMed Web of Science ®Google Scholar
• Florczuk M, Szpechcinski A, Chorostowska-Wynimko J. miRNAs as biomarkers and therapeutic targets in non-small cell lung cancer: current perspectives. Target Oncol. 2017;12(2):179–200. doi:10.1007/s11523-017-0478-528243959
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2018. doi:10.1016/j.mam.2018.07.003
   PubMed Web of Science ®Google Scholar